DOCU.NASDAQDocusign, INC

Form 4: DocuSign Director Mary Agnes Wilderotter Reports Significant RSU Activity and Increased Share Ownership

Sentiment:

Insider Transaction Report


DocuSign Director Mary Agnes Wilderotter reported the vesting of 1,069 restricted stock units into common stock and the grant of an additional 2,916 restricted stock units, increasing her total beneficial ownership to 57,616 shares.

Summary

  • Mary Agnes Wilderotter, a Director at DocuSign, Inc. (DOCU), reported changes in her beneficial ownership of company securities on May 29, 2025.
  • She acquired 1,069 shares of DocuSign common stock at a price of $0, resulting from the vesting of previously granted Restricted Stock Units (RSUs).
  • Concurrently, she was granted an additional 2,916 Restricted Stock Units (RSUs) at a price of $0.
  • Following these transactions, her total beneficial ownership of DocuSign common stock stands at 57,616 shares.
  • The 1,069 RSUs that vested had a commencement date of May 29, 2024, and vested in equal quarterly installments over one year.
  • The newly granted 2,916 RSUs have a vest commencement date of May 29, 2025, and will vest in equal quarterly installments over one year, subject to her continued service.

Sentiment

Score: 7

Explanation: The filing indicates routine equity compensation for a director, which is generally positive as it aligns interests. There are no negative financial implications or red flags. The grant of new RSUs suggests continued commitment and incentive alignment.

Positives

  • The grant of 2,916 new Restricted Stock Units to a director indicates continued alignment of management incentives with shareholder interests.
  • Increased beneficial ownership of common stock by a director (from RSU vesting) demonstrates ongoing confidence in the company's future.

Risks

  • The value of the Restricted Stock Units and the underlying common stock is subject to market fluctuations.
  • Vesting of RSUs is contingent on the reporting person remaining a service provider through the specified vesting dates.

Future Outlook

The grant of new Restricted Stock Units with a vesting schedule extending over the next year indicates an expectation of continued service from the director and aligns her incentives with the company's long-term performance.

Industry Context

This Form 4 filing details a standard insider transaction for a director receiving equity compensation. Such grants are common practice in the technology sector to align executive and director interests with shareholder value creation and are a routine part of compensation packages.

Comparison to Industry Standards

  • Equity compensation, particularly through Restricted Stock Units (RSUs), is a standard practice for compensating directors and executives in publicly traded technology companies like DocuSign.
  • The vesting schedule of quarterly installments over one year is a common structure for such grants, aiming to retain talent and incentivize long-term performance.
  • While this document does not provide specific comparative data, the nature and structure of the RSU grant are consistent with typical compensation practices observed in the broader technology industry for board members.

Stakeholder Impact

  • Shareholders: The grant of RSUs to a director aligns their interests with shareholders, as the value of the compensation is tied to the company's stock performance. Increased beneficial ownership by a director can be seen as a positive signal of confidence in the company's future.

Next Steps

  • Future vesting events for the 2,916 RSUs will occur in equal quarterly installments over one year, starting May 29, 2025.
  • The fourth quarterly installment of the 2,916 RSUs will vest on the earlier of the Company's next annual meeting of stockholders or the one-year anniversary of the grant.

Key Dates

DateDescription
05/29/2024Vest commencement date for 1,069 Restricted Stock Units.
05/29/2025Transaction date for the vesting of 1,069 Restricted Stock Units and the grant of 2,916 new Restricted Stock Units.
05/30/2025Signature date of the filing by Lisa Yun, Attorney in Fact.

Recommendation

hold

Keywords

DocuSign, DOCU, Form 4, SEC Filing, Insider Trading, Restricted Stock Units, RSU, Beneficial Ownership, Director Compensation, Equity Grant, Stock Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.